CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.
July 2nd 2025
The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.
Onivyde Fails to Improve Survival Over Chemotherapy in Second-Line Small Cell Lung Cancer
August 5th 2022Treatment with Onivyde failed to best the chemotherapy topotecan in improving overall survival in patients with small cell lung cancer whose disease failed to respond to platinum-based first-line treatment, according to findings from a primary analysis of the phase 3 RESILIENT trial.
Injectable Tecentriq Is Efficacious, Reduces Treatment Time for Lung Cancer
August 2nd 2022Subcutaneous (injectable) Tecentriq had similar movement throughout the body, while saving on treatment time compared to intravenous administration of the drug in a group of patients with non-small cell lung cancer.
Cosela May Decrease Chemo-Related Blood Complications During Lung Cancer Treatment
July 18th 2022Cosela tended to decrease myelosuppressive events — when the bone marrow is not working sufficiently to produce blood cells and platelets — in patients receiving chemotherapy for extensive-stage small cell lung cancer.
A Paradigm Shift in the Treatment of Early-Stage Lung Cancer May Be Leading to More Cures
June 16th 2022Instead of waiting until the disease has progressed, researchers have begun analyzing the effects of using immunotherapy before or after surgery in patients with early-stage lung cancer. The results, according to experts, may be transformative for patients.